Surface Oncology (SURF) EBITDA (2018 - 2023)
Surface Oncology (SURF) EBITDA from Jun 30, 2018 to Jun 30, 2023. The TTM Surface Oncology (SURF) EBITDA is -$84M. You can adjust inflation or export chart.
Annual EBITDA
Quarterly EBITDA
Surface Oncology (SURF) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +41.06% |
| 3 Years TTM | +51.22% |
| 5 Years TTM | +38.72% |
| All Time TTM | +16.38% |
Annual EBITDA change of Surface Oncology (SURF)
| Year | EBITDA | Change |
|---|---|---|
| 2023 | -$40M | -34.28% |
| 2022 | -$61M | -18.73% |
| 2021 | -$74M | -217.67% |
| 2020 | $63M | -213.82% |
| 2019 | -$56M | +612.56% |
| 2018 | -$7.80M | N/A |